Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?

AIDS-related cryptococcal meningitis continues to cause a substantial burden of death in low and middle income countries. Better diagnostics allow detection of cryptococcosis in the asymptomatic phase and using these technologies to screen at-risk persons would likely reduce mortality. The World Hea...

Full description

Bibliographic Details
Main Author: José E. Vidal
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Journal of Fungi
Subjects:
Online Access:http://www.mdpi.com/2309-608X/2/2/14
_version_ 1818946030774779904
author José E. Vidal
author_facet José E. Vidal
author_sort José E. Vidal
collection DOAJ
description AIDS-related cryptococcal meningitis continues to cause a substantial burden of death in low and middle income countries. Better diagnostics allow detection of cryptococcosis in the asymptomatic phase and using these technologies to screen at-risk persons would likely reduce mortality. The World Health Organization recommends cryptococcal antigen screening among populations with a prevalence of cryptococcal antigenaemia (CRAG) > 3%. There is scarce data about CRAG prevalence in Latin America. Four studies (only one published as a full text) showed asymptomatic CRAG prevalence between 2.7% and 6.2% in several sub-sets of HIV-infected patients. The CRAG lateral flow assay (LFA) has several advantages over other techniques for actual implementation of a screening program. Although more studies are necessary to confirm available data, implementation of the CRAG screening strategy seems to be opportune in Latin America.
first_indexed 2024-12-20T08:08:32Z
format Article
id doaj.art-ced4af151d6349aea6fcda9265c5f066
institution Directory Open Access Journal
issn 2309-608X
language English
last_indexed 2024-12-20T08:08:32Z
publishDate 2016-05-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj.art-ced4af151d6349aea6fcda9265c5f0662022-12-21T19:47:21ZengMDPI AGJournal of Fungi2309-608X2016-05-01221410.3390/jof2020014jof2020014Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?José E. Vidal0Department of Neurology; Emilio Ribas Institute of Infectious Diseases; Av Doutor Arnaldo 165, Cerqueira César, São Paulo, CEP 05411-000, BrazilAIDS-related cryptococcal meningitis continues to cause a substantial burden of death in low and middle income countries. Better diagnostics allow detection of cryptococcosis in the asymptomatic phase and using these technologies to screen at-risk persons would likely reduce mortality. The World Health Organization recommends cryptococcal antigen screening among populations with a prevalence of cryptococcal antigenaemia (CRAG) > 3%. There is scarce data about CRAG prevalence in Latin America. Four studies (only one published as a full text) showed asymptomatic CRAG prevalence between 2.7% and 6.2% in several sub-sets of HIV-infected patients. The CRAG lateral flow assay (LFA) has several advantages over other techniques for actual implementation of a screening program. Although more studies are necessary to confirm available data, implementation of the CRAG screening strategy seems to be opportune in Latin America.http://www.mdpi.com/2309-608X/2/2/14cryptococcal antigencryptococcal meningitisscreeningpreemptive therapy
spellingShingle José E. Vidal
Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?
Journal of Fungi
cryptococcal antigen
cryptococcal meningitis
screening
preemptive therapy
title Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?
title_full Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?
title_fullStr Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?
title_full_unstemmed Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?
title_short Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?
title_sort preemptive therapy for cryptococcal meningitis a valid strategy for latin america
topic cryptococcal antigen
cryptococcal meningitis
screening
preemptive therapy
url http://www.mdpi.com/2309-608X/2/2/14
work_keys_str_mv AT joseevidal preemptivetherapyforcryptococcalmeningitisavalidstrategyforlatinamerica